The report "Single Use Assemblies Market by Product (Bag (2D, 3D), Filtration, Bottle, Mixing, Tubing Assemblies), Solution (Customized, Standard), Modality (mAbs, Vaccines, CGT), Application (Filtration, Cell Culture, Storage, Transfer) - Global Forecasts to 2029", is projected to reach USD 4.89 billion by 2029 from an estimated USD 2.63 billion in 2024, at a CAGR of 13.2% during the forecast period.
Browse 470 market data Tables and 58 Figures spread through 427 Pages and in-depth TOC on "Single Use Assemblies Market by Product (Bag (2D, 3D), Filtration, Bottle, Mixing, Tubing Assemblies), Solution (Customized, Standard), Modality (mAbs, Vaccines, CGT), Application (Filtration, Cell Culture, Storage, Transfer) - Global Forecasts to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/single-use-assemblies-market-46226549.html
The Single-Use Assemblies (SUA) market is expanding rapidly, driven by the growing adoption of single-use technologies in biopharmaceutical manufacturing. According to BioPlan's 21st Annual Report and Survey, SUS usage reached 87% in 2024. These systems are preferred for their ability to reduce contamination risks, streamline operations, and support flexible production processes. They are widely used in upstream and downstream processes, particularly in biologics, vaccines, and cell and gene therapies. The shift towards modular and continuous manufacturing facilities is further fuelling demand. While challenges such as material standardization and sustainability persist, innovations in material science and the rising focus on reducing environmental impact are reshaping the market’s future trajectory.
The filtration purification segment accounted for the largest share of the application segment in the single-use assemblies market in 2023.
Based on application, the single-use assemblies services market is segmented into filtration purification applications, aseptic transfer, storage applications, sampling applications, cell culture, formulation fill-finish applications, and mixing applications. The filtration purification segment dominated the single-use assemblies market in 2023, playing a crucial role in ensuring sterility and removing contaminants in biopharmaceutical production. The rise in regulatory approvals for biopharmaceuticals and biosimilars has pushed manufacturers to adopt cost-effective single-use filtration assemblies. These assemblies, used in upstream and downstream processes, offer advantages over traditional stainless-steel systems by eliminating cleaning, sterilization, and validation needs, reducing costs and contamination risks. Single-use technologies also cut process wastage, labor costs, and quality requirements, enhancing efficiency and safety. Their flexibility allows for customized configurations, streamlining production. Initially limited to labs, single-use systems are now vital in pharmaceutical manufacturing, particularly for bioburden reduction and virus capture in gene therapies and vaccines. This shift underscores their importance in modern biopharmaceutical production, ensuring faster market entry and improved efficiency.
The CROs CMOs segment is estimated to register the highest growth rate during the forecast period in the single-use assemblies products market.
Based on end user, the single-use assemblies market is segmented into pharmaceutical biopharmaceutical companies, CROs CMOs, and academic research institutes. The CROs CMOs companies segment is estimated to register the highest growth rate during the forecast period. The increasing demand for outsourcing services among pharmaceutical biopharmaceutical industries is anticipated to promote the growth of the CROs CMOs segment in coming years. This growth is driven by the increasing preference for outsourcing research and manufacturing activities among pharmaceutical, biopharmaceutical, and biotechnology companies. CROs and CMOs provide a range of services, including drug discovery, clinical-scale manufacturing, preclinical and clinical trials, and commercial manufacturing, helping companies reduce operational costs. Despite CROs CDMOs high growth rate, Pharmaceutical Biotechnology companies accounted for the largest share of the single-use assemblies market in 2023.
North America accounted for the largest market share in the single-use assemblies market in 2023
Based on the region, the single-use assemblies market is segmented into six major regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The Asia Pacific region anticipated to register the fastest growth due to significant biopharmaceutical investments, growing RD funding, and a booming healthcare sector. India and China are key growth hotspots, driven by their large populations and the rise of CMOs with US FDA approvals and GMP certifications. Meanwhile, North America, comprising the US and Canada, is the largest regional segment, serving as a global hub for pharmaceutical and biotechnology innovation. The region benefits from robust RD infrastructure, high RD spending, and a strong intellectual property system. Major players like Danaher Corporation and Thermo Fisher Scientific have a strong presence, supported by the growing demand for advanced bioprocessing technologies and therapies. However, challenges related to plastic-based disposable products and stringent regulations may restrain growth in North America.
The report profiles key players in the single-use assemblies market such as Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), Danaher Corporation (US), Merck KGaA (Germany), Avantor, Inc. (US), Parker Hannfin Corporation (US), Saint-Gobain (France), Repligen Corporation (US), Corning Incorporated (US), Entregris (US), Lonza (US), Zacros Corporation (Japan), and W. L. Gore Associates, Inc. (US) among others.
